Influenza Vaccine for Older Patients Covered under Medicare Part B

Fluzone® High-Dose Influenza vaccine for patients age 65 and older will be a payable benefit under Medicare Part B, according to the Centers for Medicare and Medicaid Services (CMS) in its July 2010 AWP NDC – HCPCS Crosswalk File. The vaccine contains an increased amount of antigen compared to standard-dose influenza vaccines, and is designed to help generate a strong immune response in older patients. View the CDC’s Advisory Committee on Immunization Practices (ACIP) recommendations for the use of Fluzone High-Dose vaccine.

Click here for more information and links.


Share this Post